We thus evaluated FOXD1 and Gal-3 gene expression in lung cancer patients from the SurvExpress database (LUAD-TCGA and Lung Meta-base) and found high FOXD1 and Gal-3 expression in the high-risk group (Figure 1E). This evidence concerns the gene FOXD1 and lung cancer.